Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Close this folder8. Reviewing a new drug: is it a therapeutic advance?
View the document8.1 Introduction
View the document8.2 When is a new treatment a therapeutic advance?
Open this folder and view contents8.3 Collecting evidence about the drug
Open this folder and view contents8.4 Evaluation in terms of efficacy, harm and convenience
Close this folder8.5 Judging the overall value of the drug
View the document8.5.1 Considering the new drug in the local and individual context
View the document8.5.2 Overall rating scales
Open this folder and view contents8.6 Cost
View the document8.7 What patients need to know
View the document8.8 References
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

8.5.2 Overall rating scales

Some bulletins use a rating scale, with a picture or shorthand phrase to indicate the overall judgement on a new drug. See Boxes 8.6 and 8.7 for examples.

Box 8.6 Rating scale for new products used by la revue Prescrire, France

Bravo
A real advance
Offers an advantage
Possibly helpful
Nothing new
Not acceptable
Judgement reserved

[http://www.prescrire.org]

Box 8.7 Rating scale used by Worst Pills, Best Pills, USA

Do not use
Limited use
Do not use until five years after release

Note that there is no "Use" category per se.

[http://www.worstpills.org/]

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014